Month: May 2021

The Covid-19 pandemic now appears to be the worst it has ever been, with daily new cases worldwide topping 800,000 several times over the past week. More new cases have been reported in the past two weeks than in the first six months of the crisis. More than one in three of these new cases were reported in India, the world’s second-most-populous country and now the epicenter of Covid-19. The rising infections, deaths, and strained health system have created a humanitarian crisis, one that may not relent for months. Other parts of the world that have barely begun to vaccinate people may soon see their own surges in Covid-19. What’s complicating the situation is the rise of new variants of SARS-CoV-2, the virus that causes Covid-19. Several of these variants contain mutations t...

Press release from the Humboldt County Joint Information Center: Nine new cases of COVID-19 were reported today, and one previously reported case has been determined through a confirmatory PCR test to be negative and has been removed from the count. The total number of county residents who have tested positive now stands at 3,903.   Humboldt County Public Health and other approved local vaccinators have administered 98,226 doses of COVID-19 vaccine. Vaccine data on the Humboldt County Data Dashboard has been updated. Some highlights include: 60,462 Humboldt County residents have received at least one dose of COVID-19 vaccine, meaning they have some protection against the virus. That represents 45% of the total population and 54% of the county’s population age 16 and older who...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...

SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah. A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release. The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah. "He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case. The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...